It was found that 500-kDa HA stimulated ABCB1 expression via CD44 in breast cancer (MCF-7 cells), inducing resistance to doxorubicin, paclitaxel, and etoposide [11,28]. The gene discussed is CD44; the disease is breast carcinoma.